Fondazione Epatocentro Ticino Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03699839
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fondazione Epatocentro Ticino